Multidisciplinary Collaboration: Best Practices for CSCC and BCC Management

EP: 1.Prevalence of Cutaneous Squamous Cell Carcinoma (CSCC) & Basal Cell Carcinoma (BCC)

EP: 2.Immunotherapy Landscape in cSCC and BCC

EP: 3.Immunotherapy and Radiation Therapy in cSCC and BCC

EP: 4.Immunotherapy Barriers: Multidisciplinary Approach in cSCC and BCC

EP: 5.Coordination of Care: Interdisciplinary Immunotherapy Challenges in Nonmelanoma Skin Cancers

Now Viewing

EP: 6.Multidisciplinary Collaboration: Best Practices for CSCC and BCC Management

EP: 7.Dermatologists and Immunotherapy: Managing Patient Expectations

EP: 8.Monitoring Immunotherapy Toxicities in CSCC and BCC

EP: 9.Staging Disease and Risk Stratification in CSCC and BCC

EP: 10.Targeted Therapy: Hedgehog Inhibitors in BCC

EP: 11.Socioeconomic Implications of CSCC and BCC

EP: 12.Immunosuppression in CSCC and BCC Treatment

EP: 13.Updates in Therapeutics for Nonmelanoma Skin Cancers

EP: 14.Concluding Thoughts on the Future of CSCC and BCC Care

This is a video synopsis/summary of a Peer Exchange involving Jason Luke, MD, FACP; Christopher Barker, MD; Omid Hamid, MD; Vishal Patel, MD; and Catherine Pisano, MD.

Pisano outlined the coordinated intake process at her center, including a dedicated nonmelanoma tumor board with dermatology, medical and radiation oncology, head and neck surgery, and surgical oncology. This enables rapid pathology review, imaging access, and subspecialty evaluations so patients start optimized treatment quickly. Luke noted the importance as a medical oncologist of seeing geographically distant patient referrals, as the clinical scenario may differ from the referral details. He suggested medical oncologists should view themselves as quarterbacks to appropriately triage and coordinate care. Patel agreed playing this role and having at least an initial discussion enables complex patients to get connected to local treatment. Hamid stated current technologies facilitate coordination, including virtual video visits with patients to obviate travel and easily convening joint tumor boards. While subspecialists need not attend weekly meetings, periodic participation allows for information dissemination and ensures evidence-based care. The discussants concluded leveraging technology solutions can enhance collaboration to raise the standard of care for patients regionally and nationally.

Video synopsis is AI-generated and reviewed by AJMC® editorial staff.